CT Financial Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

CT Financial Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$8K	Hold	150	–	–	﹤0.01%	474
2016 Q4	$7.49K	Hold	150	–	–	﹤0.01%	474
2016 Q3	$9.01K	Hold	150	–	–	0.01%	447
2016 Q2	$7.67K	Hold	150	–	–	﹤0.01%	457
2016 Q1	$4.43K	Hold	150	–	–	﹤0.01%	518
2015 Q4	$6.8K	Hold	150	–	–	﹤0.01%	490
2015 Q3	$6.26K	Hold	150	–	–	﹤0.01%	507
2015 Q2	$9.04K	Buy	+150	New	+$9.92K	0.01%	478

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SMV

Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return

CT Financial Advisors's ONCE Position: Q1 2017 in Review

CT Financial Advisors held its Spark Therapeutics, Inc. Common Stock (ONCE) position steady in Q1 2017 at 150 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #474.

CT Financial Advisors first reported a position in ONCE in Q2 2015 and has held it in 8 quarters since. The position peaked at $9.04K in Q2 2015. 122 funds tracked by Wall St. Rank hold ONCE as of Q1 2017.

CT Financial Advisors held 150 shares of Spark Therapeutics, Inc. Common Stock worth $8K as of Q1 2017.
CT Financial Advisors left its Spark Therapeutics, Inc. Common Stock share count unchanged in Q1 2017.
Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #474 holding.
CT Financial Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 8 quarters since.
CT Financial Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $9.04K in Q2 2015.
122 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.